Adrien Laroche

Deep mutational engineering of broadly-neutralizing nanobodies accommodating SARS-CoV-1 and 2 antigenic drift

H. Nozach, P. Cuniasse, S. Simon, 2022, mAbs.

A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions

A. Poupon, V. Gouilleux-Gruart, M. Jarlier, 2019, mAbs.